SILTUXIMAB

SILTUXIMAB was reported 649 times

SILTUXIMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BCG RELATED CYSTITIS 8 0.4000
1 SHORT STATURE 30 0.1145
2 IMMUNE EFFECTOR CELL-ASSOCIATED HAEMATOTOXICITY 19 0.1092
3 RETICULOENDOTHELIAL SYSTEM STIMULATED 1 0.1000
4 SPINAL INSTABILITY 25 0.0984
5 ATLANTOAXIAL INSTABILITY 9 0.0811
6 RETINAL ANOMALY CONGENITAL 2 0.0800
7 IMMUNE EFFECTOR CELL-ASSOCIATED HLH-LIKE SYNDROME 8 0.0530
8 OESOPHAGOMEDIASTINAL FISTULA 1 0.0500
9 NEURONAL NEUROPATHY 1 0.0476
10 SIGMOID SINUS THROMBOSIS 2 0.0303
11 LYMPHODEPLETION 1 0.0294
12 MENINGITIS CANDIDA 2 0.0286
13 ACHROMOBACTER INFECTION 3 0.0250
14 PANCREATIC FIBROSIS 1 0.0196
15 CYSTITIS VIRAL 7 0.0183
16 HUMAN HERPESVIRUS 6 ENCEPHALITIS 5 0.0176
17 RELAPSING FEVER 5 0.0173
18 NASAL FLARING 2 0.0149
19 INTESTINAL MUCOSAL TEAR 1 0.0141
20 STEATOHEPATITIS 7 0.0131
21 HEPATIC INFECTION BACTERIAL 1 0.0128
22 DISSEMINATED VARICELLA ZOSTER VACCINE VIRUS INFECTION 1 0.0127
23 SPINAL CORD OPERATION 2 0.0105
24 POEMS SYNDROME 1 0.0095
25 PROPIONIBACTERIUM INFECTION 1 0.0093
26 CUSHINGOID 30 0.0093
27 ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD 1 0.0091
28 PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA 1 0.0085
29 CAR T-CELL-RELATED ENCEPHALOPATHY SYNDROME 1 0.0081
30 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 47 0.0079
31 PURPURA FULMINANS 2 0.0079
32 PARANEOPLASTIC PEMPHIGUS 1 0.0077
33 STENOTROPHOMONAS TEST POSITIVE 1 0.0075
34 PNEUMONIA ACINETOBACTER 1 0.0073
35 ADENOVIRUS REACTIVATION 1 0.0069
36 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 9 0.0068
37 RETINOPATHY HYPERTENSIVE 2 0.0066
38 OESOPHAGOBRONCHIAL FISTULA 1 0.0066
39 VASCULAR COMPRESSION 2 0.0063
40 GROWTH RETARDATION 18 0.0061
41 DIFFUSE LARGE B-CELL LYMPHOMA STAGE IV 2 0.0061
42 INTERLEUKIN LEVEL INCREASED 3 0.0054
43 ACINETOBACTER BACTERAEMIA 1 0.0053
44 ENGRAFTMENT SYNDROME 3 0.0051
45 PULSE PRESSURE INCREASED 1 0.0048
46 CHLOROMA 2 0.0047
47 ENTEROCOCCAL BACTERAEMIA 5 0.0047
48 OSTEOPOROTIC FRACTURE 9 0.0047
49 HYPERFERRITINAEMIA 2 0.0046
50 ENDOTHELIAL DYSFUNCTION 1 0.0043
51 EUSTACHIAN TUBE DISORDER 1 0.0042
52 JEJUNAL PERFORATION 1 0.0041
53 B-CELL APLASIA 1 0.0039
54 CYTOTOXIC OEDEMA 1 0.0038
55 HAEMOSIDEROSIS 1 0.0037
56 LYMPHOCYTE ADOPTIVE THERAPY 1 0.0036
57 BLOOD FIBRINOGEN DECREASED 4 0.0035
58 BK VIRUS INFECTION 11 0.0033
59 CYTOKINE RELEASE SYNDROME 60 0.0030
60 OXYGEN SATURATION INCREASED 1 0.0029
61 OSTEOLYSIS 6 0.0029
62 CYTOKINE STORM 2 0.0029
63 BASAL GANGLIA INFARCTION 1 0.0029
64 JUVENILE IDIOPATHIC ARTHRITIS 7 0.0029
65 POLYOMAVIRUS VIRAEMIA 3 0.0028
66 HERPES ZOSTER MENINGOENCEPHALITIS 1 0.0028
67 LYMPHADENOPATHY MEDIASTINAL 5 0.0026
68 RHINOVIRUS INFECTION 10 0.0026
69 CRITICAL ILLNESS 2 0.0026
70 PARVOVIRUS INFECTION 1 0.0025
71 PERICARDITIS CONSTRICTIVE 1 0.0024
72 PSEUDOMONAL BACTERAEMIA 2 0.0023
73 AMYLOIDOSIS 4 0.0023
74 SERUM FERRITIN DECREASED 4 0.0023
75 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 17 0.0023
76 MENINGOENCEPHALITIS HERPETIC 1 0.0022
77 PNEUMONIA VIRAL 7 0.0022
78 HYPERMETROPIA 2 0.0021
79 HYPERGAMMAGLOBULINAEMIA 1 0.0021
80 IMMUNODEFICIENCY COMMON VARIABLE 1 0.0020
81 MASTOIDITIS 2 0.0020
82 CYTOMEGALOVIRUS INFECTION REACTIVATION 9 0.0020
83 HYPOHIDROSIS 1 0.0020
84 BONE EROSION 7 0.0020
85 OSTEOPENIA 30 0.0020
86 DISSEMINATED TUBERCULOSIS 5 0.0019
87 CAROTID ARTERIOSCLEROSIS 2 0.0019
88 POLYCYTHAEMIA 4 0.0019
89 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 5 0.0019
90 NON-ALCOHOLIC STEATOHEPATITIS 2 0.0019
91 ENTEROCOCCAL INFECTION 9 0.0019
92 BLOOD GASES ABNORMAL 1 0.0019
93 DIFFUSE LARGE B-CELL LYMPHOMA 14 0.0018
94 REPETITIVE SPEECH 1 0.0018
95 HYPERTRIGLYCERIDAEMIA 10 0.0017
96 IRREGULAR BREATHING 1 0.0017
97 DROP ATTACKS 1 0.0017
98 HEPATIC STEATOSIS 31 0.0017
99 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 2 0.0016
100 SYSTEMIC CANDIDA 4 0.0016
101 TRACHEO-OESOPHAGEAL FISTULA 1 0.0016
102 URINARY SEDIMENT PRESENT 1 0.0016
103 APLASIA 3 0.0015
104 PNEUMOTHORAX SPONTANEOUS 1 0.0015
105 ACUTE LYMPHOCYTIC LEUKAEMIA 4 0.0014
106 VIRAL HAEMORRHAGIC CYSTITIS 1 0.0014
107 NONINFECTIVE ENCEPHALITIS 1 0.0014
108 TOXIC LEUKOENCEPHALOPATHY 1 0.0014
109 SYMPTOM MASKED 1 0.0014
110 BRAIN STEM SYNDROME 1 0.0013
111 ASTIGMATISM 2 0.0013
112 MALIGNANT ASCITES 1 0.0013
113 FUNGAEMIA 2 0.0013
114 SUPERINFECTION BACTERIAL 1 0.0013
115 HAPTOGLOBIN DECREASED 1 0.0012
116 POLYCYTHAEMIA VERA 1 0.0012
117 CEREBRAL VENOUS SINUS THROMBOSIS 1 0.0012
118 HEPATOSPLENOMEGALY 3 0.0012
119 AUTOIMMUNE HAEMOLYTIC ANAEMIA 4 0.0012
120 MALIGNANT HYPERTENSION 1 0.0012
121 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 3 0.0011
122 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 33 0.0011
123 CYTOMEGALOVIRUS VIRAEMIA 5 0.0011
124 URINARY TRACT INFECTION ENTEROCOCCAL 1 0.0011
125 FRACTURE 20 0.0011
126 HYPERCHOLESTEROLAEMIA 10 0.0010
127 DEVICE RELATED THROMBOSIS 1 0.0010
128 INFLAMMATORY MARKER INCREASED 5 0.0010
129 MUCOSAL DISORDER 1 0.0010
130 SKIN OEDEMA 1 0.0010
131 AUTONOMIC NEUROPATHY 1 0.0010
132 SUSPECTED PRODUCT CONTAMINATION 1 0.0010
133 DEMYELINATING POLYNEUROPATHY 1 0.0010
134 CONSCIOUSNESS FLUCTUATING 1 0.0010
135 EXOPHTHALMOS 2 0.0009
136 AMAUROSIS FUGAX 1 0.0009
137 STREPTOCOCCAL BACTERAEMIA 1 0.0009
138 PRODUCT NAME CONFUSION 1 0.0009
139 RETROPERITONEAL HAEMATOMA 2 0.0009
140 EMBOLIC STROKE 3 0.0009
141 HYPORESPONSIVE TO STIMULI 1 0.0009
142 FIBRIN D DIMER INCREASED 3 0.0008
143 CLOSTRIDIUM COLITIS 1 0.0008
144 CEREBRAL ARTERY EMBOLISM 1 0.0008
145 SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT 1 0.0008
146 HOSTILITY 2 0.0008
147 BLOOD BILIRUBIN ABNORMAL 1 0.0008
148 BRONCHOPULMONARY ASPERGILLOSIS 6 0.0008
149 MUCORMYCOSIS 2 0.0008
150 EXFOLIATIVE RASH 2 0.0008
151 MENINGITIS VIRAL 1 0.0007
152 NEPHROPATHY TOXIC 8 0.0007
153 NECK MASS 2 0.0007
154 RESPIRATORY SYMPTOM 2 0.0007
155 CEREBELLAR HAEMORRHAGE 1 0.0007
156 RENAL INFARCT 1 0.0007
157 STAPHYLOCOCCAL BACTERAEMIA 3 0.0007
158 MUTISM 1 0.0007
159 PULMONARY SEPSIS 1 0.0007
160 MULTIPLE ORGAN DYSFUNCTION SYNDROME 19 0.0007
161 SECONDARY ADRENOCORTICAL INSUFFICIENCY 1 0.0007
162 HAEMOGLOBIN INCREASED 3 0.0007
163 ISCHAEMIA 3 0.0007
164 LOSS OF THERAPEUTIC RESPONSE 2 0.0006
165 STRONGYLOIDIASIS 1 0.0006
166 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 3 0.0006
167 PUPIL FIXED 1 0.0006
168 SOFT TISSUE INFECTION 1 0.0005
169 CATARACT 32 0.0005
170 ENCEPHALOPATHY 13 0.0005
171 HUMAN HERPESVIRUS 6 INFECTION 1 0.0005
172 BLOOD BICARBONATE DECREASED 1 0.0005
173 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 5 0.0005
174 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 2 0.0005
175 OPTIC ISCHAEMIC NEUROPATHY 2 0.0005
176 NEUROTOXICITY 9 0.0005
177 HEPATOMEGALY 5 0.0005
178 MULTI-ORGAN DISORDER 1 0.0005
179 PNEUMONIA FUNGAL 2 0.0005
180 PNEUMONIA STAPHYLOCOCCAL 1 0.0005
181 BACTERAEMIA 6 0.0005
182 CELL DEATH 1 0.0005
183 SMALL INTESTINAL HAEMORRHAGE 1 0.0005
184 ORGAN FAILURE 2 0.0005
185 CYTOPENIA 6 0.0005
186 EXTRAVASATION 2 0.0005
187 NEUTROPENIC COLITIS 1 0.0005
188 WALKING DISABILITY 1 0.0005
189 LUNG ABSCESS 1 0.0005
190 PSEUDOMONAS INFECTION 4 0.0005
191 HYPERPHOSPHATAEMIA 1 0.0005
192 ACUTE RESPIRATORY DISTRESS SYNDROME 8 0.0005
193 DISTRIBUTIVE SHOCK 1 0.0004
194 HAEMATOCRIT INCREASED 1 0.0004
195 PANCREATITIS NECROTISING 1 0.0004
196 SINUS PAIN 1 0.0004
197 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 11 0.0004
198 SPLENOMEGALY 5 0.0004
199 DISSEMINATED INTRAVASCULAR COAGULATION 6 0.0004
200 DISTURBANCE IN SOCIAL BEHAVIOUR 1 0.0004
201 VIRAL UPPER RESPIRATORY TRACT INFECTION 2 0.0004
202 INTRA-ABDOMINAL HAEMORRHAGE 1 0.0004
203 RENAL DISORDER 19 0.0004
204 EYE OEDEMA 1 0.0004
205 RETROPERITONEAL HAEMORRHAGE 1 0.0004
206 HYPERNATRAEMIA 2 0.0004
207 NEUTROPHIL COUNT INCREASED 4 0.0004
208 ABNORMAL UTERINE BLEEDING 1 0.0004
209 PRODUCT PREPARATION ERROR 8 0.0004
210 CEREBRAL ISCHAEMIA 2 0.0004
211 PERIORBITAL OEDEMA 2 0.0004
212 PULMONARY HAEMORRHAGE 3 0.0004
213 MUCOSAL INFLAMMATION 10 0.0004
214 AREFLEXIA 1 0.0004
215 NEOPLASM PROGRESSION 13 0.0004
216 BRADYPNOEA 1 0.0004
217 FOOT FRACTURE 7 0.0004
218 ACUTE RESPIRATORY FAILURE 7 0.0004
219 CYTOMEGALOVIRUS INFECTION 6 0.0004
220 MYELOSUPPRESSION 13 0.0004
221 LYMPHOPENIA 5 0.0004
222 VITAMIN B12 DECREASED 1 0.0003
223 PERIPHERAL SENSORY NEUROPATHY 2 0.0003
224 DISEASE PROGRESSION 40 0.0003
225 PLEURISY 2 0.0003
226 BRAIN HERNIATION 1 0.0003
227 METABOLIC ENCEPHALOPATHY 1 0.0003
228 EMERGENCY CARE 1 0.0003
229 ARTHROPATHY 18 0.0003
230 BRAIN DEATH 1 0.0003
231 GENERALISED OEDEMA 4 0.0003
232 AGRANULOCYTOSIS 6 0.0003
233 ELECTROENCEPHALOGRAM ABNORMAL 1 0.0003
234 HEPATITIS B REACTIVATION 1 0.0003
235 HAEMOGLOBIN ABNORMAL 2 0.0003
236 THROMBOTIC MICROANGIOPATHY 3 0.0003
237 RENAL TUBULAR NECROSIS 3 0.0003
238 PRODUCT PREPARATION ISSUE 2 0.0003
239 ASPERGILLUS INFECTION 2 0.0003
240 OTITIS MEDIA 1 0.0003
241 BRAIN INJURY 3 0.0003
242 PNEUMOCYSTIS JIROVECII PNEUMONIA 3 0.0003
243 SEPTIC SHOCK 13 0.0003
244 LEFT VENTRICULAR DYSFUNCTION 2 0.0003
245 NEOPLASM RECURRENCE 1 0.0003
246 ENCEPHALITIS 2 0.0003
247 CAROTID ARTERY STENOSIS 1 0.0003
248 VENTRICULAR ARRHYTHMIA 1 0.0003
249 MOUTH HAEMORRHAGE 2 0.0003
250 ASCITES 8 0.0003
251 PULMONARY MASS 4 0.0003
252 LEUKOENCEPHALOPATHY 1 0.0003
253 HEPATIC NECROSIS 1 0.0003
254 HAEMODYNAMIC INSTABILITY 2 0.0003
255 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 14 0.0003
256 LYMPHADENOPATHY 9 0.0003
257 COVID-19 PNEUMONIA 3 0.0003
258 FURUNCLE 2 0.0003
259 RENAL CYST 2 0.0003
260 HYPERURICAEMIA 1 0.0002
261 RED CELL DISTRIBUTION WIDTH INCREASED 1 0.0002
262 GASTROINTESTINAL PERFORATION 1 0.0002
263 PULSELESS ELECTRICAL ACTIVITY 1 0.0002
264 HEPATIC CYTOLYSIS 3 0.0002
265 PULMONARY TUBERCULOSIS 1 0.0002
266 LIVER FUNCTION TEST INCREASED 5 0.0002
267 METASTATIC NEOPLASM 1 0.0002
268 DYSPHEMIA 1 0.0002
269 TUMOUR LYSIS SYNDROME 2 0.0002
270 ABDOMINAL ABSCESS 1 0.0002
271 ANAL INCONTINENCE 2 0.0002
272 SUSPECTED OFF LABEL USE 1 0.0002
273 IMMUNE THROMBOCYTOPENIA 1 0.0002
274 SHOCK 5 0.0002
275 BACTERIAL INFECTION 4 0.0002
276 STAPHYLOCOCCAL INFECTION 7 0.0002
277 HYPERTENSION 44 0.0002
278 HAEMORRHOIDAL HAEMORRHAGE 1 0.0002
279 HYPERVOLAEMIA 1 0.0002
280 ORGANISING PNEUMONIA 1 0.0002
281 TOXIC EPIDERMAL NECROLYSIS 3 0.0002
282 CACHEXIA 1 0.0002
283 HYPERBILIRUBINAEMIA 2 0.0002
284 SKIN NECROSIS 1 0.0002
285 FAILURE TO THRIVE 1 0.0002
286 C-REACTIVE PROTEIN INCREASED 7 0.0002
287 BLOOD LACTIC ACID INCREASED 1 0.0002
288 SERUM FERRITIN INCREASED 1 0.0002
289 CLOSTRIDIUM DIFFICILE COLITIS 2 0.0002
290 NORMAL NEWBORN 1 0.0002
291 STEVENS-JOHNSON SYNDROME 4 0.0002
292 PLASMA CELL MYELOMA 7 0.0002
293 PANCYTOPENIA 10 0.0002
294 MALNUTRITION 2 0.0002
295 ANGIOPATHY 1 0.0002
296 INTESTINAL PERFORATION 2 0.0002
297 MYOCARDITIS 2 0.0002
298 PERICARDIAL EFFUSION 4 0.0002
299 GLUCOSE TOLERANCE IMPAIRED 1 0.0002
300 PROTHROMBIN TIME PROLONGED 1 0.0002
301 LEUKOCYTOSIS 3 0.0002
302 LOCALISED INFECTION 4 0.0002
303 PLEURAL EFFUSION 10 0.0002
304 LUNG DISORDER 8 0.0002
305 INJECTION SITE EXTRAVASATION 2 0.0002
306 OFF LABEL USE 140 0.0002
307 BRAIN OEDEMA 2 0.0002
308 WHITE BLOOD CELL COUNT ABNORMAL 1 0.0002
309 INTRAOCULAR PRESSURE INCREASED 2 0.0002
310 C-REACTIVE PROTEIN ABNORMAL 1 0.0002
311 NIGHT SWEATS 5 0.0002
312 ANAPHYLACTIC SHOCK 4 0.0002
313 HERPES SIMPLEX 1 0.0002
314 NODULE 2 0.0002
315 NEPHROLITHIASIS 7 0.0002
316 THROMBOCYTOPENIA 17 0.0002
317 WALKING AID USER 1 0.0002
318 CORONAVIRUS INFECTION 1 0.0002
319 ACUTE KIDNEY INJURY 23 0.0002
320 CARDIAC FAILURE ACUTE 1 0.0001
321 BONE MARROW FAILURE 3 0.0001
322 NEUTROPHIL COUNT DECREASED 6 0.0001
323 HYPERTRANSAMINASAEMIA 1 0.0001
324 EXTRASYSTOLES 1 0.0001
325 PULMONARY TOXICITY 1 0.0001
326 GRAFT VERSUS HOST DISEASE 1 0.0001
327 VISUAL FIELD DEFECT 1 0.0001
328 RESPIRATORY FAILURE 10 0.0001
329 SENSITIVE SKIN 1 0.0001
330 CARDIOMYOPATHY 2 0.0001
331 CEREBRAL DISORDER 1 0.0001
332 RASH MACULO-PAPULAR 3 0.0001
333 IMMUNODEFICIENCY 2 0.0001
334 SUNBURN 1 0.0001
335 HAEMOLYSIS 1 0.0001
336 EJECTION FRACTION DECREASED 2 0.0001
337 HAEMORRHAGIC STROKE 1 0.0001
338 BLOOD ALBUMIN DECREASED 1 0.0001
339 MUSCLE DISORDER 1 0.0001
340 ESCHERICHIA INFECTION 1 0.0001
341 CARDIAC ARREST 10 0.0001
342 EMBOLISM 1 0.0001
343 BLOOD UREA INCREASED 2 0.0001
344 HAEMODIALYSIS 1 0.0001
345 CANDIDA INFECTION 2 0.0001
346 FACIAL PARALYSIS 1 0.0001
347 SEPSIS 13 0.0001
348 MYOPATHY 1 0.0001
349 RESPIRATORY SYNCYTIAL VIRUS INFECTION 1 0.0001
350 ARTHRITIS 9 0.0001
351 HYPERKALAEMIA 4 0.0001
352 HYPOXIA 4 0.0001
353 IMMUNOSUPPRESSION 1 0.0001
354 LUNG INFILTRATION 1 0.0001
355 PLATELET COUNT DECREASED 12 0.0001
356 WRONG TECHNIQUE IN DRUG USAGE PROCESS 4 0.0001
357 HIDRADENITIS 1 0.0001
358 PNEUMONIA BACTERIAL 1 0.0001
359 PRODUCT USE IN UNAPPROVED INDICATION 27 0.0001
360 UROSEPSIS 1 0.0001
361 CONJUNCTIVITIS 2 0.0001
362 HAEMOPTYSIS 3 0.0001
363 HEPATIC FUNCTION ABNORMAL 4 0.0001
364 FLANK PAIN 1 0.0001
365 LACERATION 1 0.0001
366 INFUSION RELATED REACTION 7 0.0001
367 PROTEINURIA 2 0.0001
368 NEUROPATHY PERIPHERAL 10 0.0001
369 SUPRAVENTRICULAR TACHYCARDIA 1 0.0001
370 CHOLESTASIS 2 0.0001
371 AFFECT LABILITY 1 0.0001
372 THERAPY CHANGE 1 0.0001
373 HEPATIC FAILURE 3 0.0001
374 HYPOTHERMIA 1 0.0001
375 SUBARACHNOID HAEMORRHAGE 1 0.0001
376 POOR VENOUS ACCESS 1 0.0001
377 CARDIAC DISORDER 9 0.0001
378 WEIGHT FLUCTUATION 1 0.0001
379 TOXICITY TO VARIOUS AGENTS 16 0.0001
380 PULMONARY EMBOLISM 9 0.0001
381 LACTIC ACIDOSIS 3 0.0001
382 PRODUCT PRESCRIBING ISSUE 2 0.0001
383 PULMONARY THROMBOSIS 1 0.0001
384 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
385 WOUND INFECTION 1 0.0001
386 NERVE INJURY 1 0.0001
387 OBSTRUCTIVE AIRWAYS DISORDER 1 0.0001
388 HYPERTENSIVE CRISIS 1 0.0001
389 ORAL PAIN 2 0.0001
390 THERAPY NON-RESPONDER 4 0.0001
391 PANCREATITIS ACUTE 2 0.0001
392 STATUS EPILEPTICUS 1 0.0001
393 HEART RATE IRREGULAR 2 0.0001
394 NEUTROPENIA 12 0.0001
395 SCAB 1 0.0001
396 COVID-19 15 0.0001
397 MYOCLONUS 1 0.0001
398 CEREBRAL HAEMORRHAGE 3 0.0001
399 RASH ERYTHEMATOUS 4 0.0001
400 POLYNEUROPATHY 1 0.0001
401 ADRENAL INSUFFICIENCY 1 0.0001
402 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
403 CARDIOMEGALY 1 0.0001
404 ILEUS 1 0.0001
405 LEUKOPENIA 4 0.0001
406 DERMATITIS ALLERGIC 1 0.0001
407 CONDITION AGGRAVATED 24 0.0001
408 DRUG DOSE OMISSION 13 0.0001
409 HYPOPHAGIA 2 0.0001
410 METASTASES TO CENTRAL NERVOUS SYSTEM 1 0.0001
411 UNRESPONSIVE TO STIMULI 2 0.0001
412 BLOOD CREATININE INCREASED 5 0.0001
413 SEDATION 2 0.0001
414 WEIGHT INCREASED 17 0.0001
415 PULMONARY CONGESTION 1 0.0001
416 DEPRESSED LEVEL OF CONSCIOUSNESS 3 0.0001
417 DISORIENTATION 3 0.0001
418 ADVERSE REACTION 1 0.0001
419 FEBRILE NEUTROPENIA 5 0.0001
420 HYPOTENSION 15 0.0001
421 DRUG INEFFECTIVE 98 0.0001
422 RESPIRATORY ARREST 2 0.0001
423 RESPIRATORY DISTRESS 2 0.0001
424 MASS 1 0.0001
425 SINUS TACHYCARDIA 1 0.0001
426 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 5 0.0001
427 INTENTIONAL DOSE OMISSION 2 0.0001
428 BRONCHOSPASM 1 0.0001
429 HYPERTHYROIDISM 1 0.0001
430 FLUID OVERLOAD 1 0.0001
431 RENAL FAILURE 9 0.0001
432 LABORATORY TEST ABNORMAL 2 0.0001
433 TACHYCARDIA 6 0.0001
434 RESPIRATORY DISORDER 2 0.0001
435 APHASIA 2 0.0001
436 OEDEMA PERIPHERAL 8 0.0001
437 DRUG ADMINISTRATION ERROR 2 0.0001
438 UPPER RESPIRATORY TRACT INFECTION 3 0.0001
439 LYMPHOMA 1 0.0001
440 MUSCULOSKELETAL CHEST PAIN 1 0.0001
441 BLOOD CHOLESTEROL INCREASED 3 0.0001
442 THERAPY PARTIAL RESPONDER 1 0.0001
443 NERVOUS SYSTEM DISORDER 2 0.0001
444 CYANOSIS 1 0.0001
445 DISEASE RECURRENCE 3 0.0001
446 PNEUMONIA 20 0.0001
447 ATRIAL FIBRILLATION 6 0.0001
448 VENTRICULAR TACHYCARDIA 1 0.0001
449 FUNGAL INFECTION 2 0.0001
450 GASTROINTESTINAL HAEMORRHAGE 5 0.0001
451 RENAL IMPAIRMENT 5 0.0001
452 HAEMATURIA 2 0.0001
453 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
454 MUSCULOSKELETAL DISCOMFORT 1 0.0001
455 DELIRIUM 2 0.0001
456 INTENTIONAL PRODUCT USE ISSUE 5 0.0001
457 PANCREATITIS 3 0.0001
458 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
459 BRADYCARDIA 3 0.0001
460 ISCHAEMIC STROKE 1 0.0001
461 OEDEMA 3 0.0001
462 TOOTHACHE 1 0.0001
463 OSTEOMYELITIS 1 0.0001
464 AGITATION 4 0.0001
465 HYPERSENSITIVITY 10 0.0001
466 THINKING ABNORMAL 1 0.0001
467 DYSARTHRIA 2 0.0001
468 DYSPNOEA EXERTIONAL 2 0.0001
469 HYPOCALCAEMIA 1 0.0001
470 COLITIS 2 0.0001
471 GASTRIC ULCER 1 0.0001
472 SLEEP APNOEA SYNDROME 1 0.0001
473 DRUG PRESCRIBING ERROR 1 0.0001
474 PYREXIA 18 0.0001
475 DYSTONIA 1 0.0001
476 BONE PAIN 3 0.0001
477 HAEMATOCRIT DECREASED 1 0.0001
478 BLOOD PRESSURE ABNORMAL 1 0.0001
479 SPINAL FRACTURE 1 0.0000
480 CARDIAC FAILURE 4 0.0000
481 STOMATITIS 3 0.0000
482 ILL-DEFINED DISORDER 3 0.0000
483 RHABDOMYOLYSIS 2 0.0000
484 PRODUCT DISPENSING ERROR 1 0.0000
485 MELAENA 1 0.0000
486 TRANSAMINASES INCREASED 1 0.0000
487 GASTROINTESTINAL DISORDER 4 0.0000
488 ADVERSE DRUG REACTION 4 0.0000
489 MUSCULAR WEAKNESS 5 0.0000
490 DEATH 37 0.0000
491 SWELLING 4 0.0000
492 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 3 0.0000
493 COMA 2 0.0000
494 PRESYNCOPE 1 0.0000
495 CEREBRAL INFARCTION 1 0.0000
496 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
497 SOMNOLENCE 8 0.0000
498 CELLULITIS 2 0.0000
499 HAEMATEMESIS 1 0.0000
500 FLUID RETENTION 2 0.0000
501 HEPATITIS 1 0.0000
502 MALIGNANT NEOPLASM PROGRESSION 4 0.0000
503 ERECTILE DYSFUNCTION 1 0.0000
504 INFLAMMATION 2 0.0000
505 RESPIRATORY TRACT INFECTION 1 0.0000
506 MENSTRUATION IRREGULAR 1 0.0000
507 THROMBOSIS 3 0.0000
508 JAUNDICE 1 0.0000
509 BLOOD BILIRUBIN INCREASED 1 0.0000
510 RASH PRURITIC 2 0.0000
511 PALLOR 1 0.0000
512 TREATMENT FAILURE 3 0.0000
513 MENTAL STATUS CHANGES 1 0.0000
514 HYPONATRAEMIA 2 0.0000
515 RED BLOOD CELL COUNT DECREASED 1 0.0000
516 HYPERSOMNIA 1 0.0000
517 HERPES ZOSTER 2 0.0000
518 SEIZURE 4 0.0000
519 INFECTION 5 0.0000
520 THERAPEUTIC RESPONSE DECREASED 2 0.0000
521 ADVERSE EVENT 3 0.0000
522 CHEST PAIN 6 0.0000
523 ANAEMIA 6 0.0000
524 HYPOTHYROIDISM 1 0.0000
525 VIRAL INFECTION 1 0.0000
526 DEHYDRATION 4 0.0000
527 RASH 13 0.0000
528 FLUSHING 3 0.0000
529 HAEMOGLOBIN DECREASED 3 0.0000
530 VISION BLURRED 4 0.0000
531 RASH MACULAR 1 0.0000
532 WHITE BLOOD CELL COUNT DECREASED 3 0.0000
533 NO ADVERSE EVENT 5 0.0000
534 RESTLESSNESS 1 0.0000
535 DYSGEUSIA 2 0.0000
536 EYE SWELLING 1 0.0000
537 PRODUCT USE ISSUE 5 0.0000
538 HALLUCINATION 2 0.0000
539 GENERAL PHYSICAL HEALTH DETERIORATION 3 0.0000
540 PARAESTHESIA 4 0.0000
541 CONFUSIONAL STATE 4 0.0000
542 DYSKINESIA 1 0.0000
543 FATIGUE 19 0.0000
544 ROAD TRAFFIC ACCIDENT 1 0.0000
545 MYALGIA 4 0.0000
546 ANGIOEDEMA 1 0.0000
547 LIVER DISORDER 1 0.0000
548 PULMONARY OEDEMA 1 0.0000
549 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
550 TINNITUS 1 0.0000
551 BACK PAIN 5 0.0000
552 VOMITING 10 0.0000
553 DYSPNOEA 12 0.0000
554 ARRHYTHMIA 1 0.0000
555 INTERSTITIAL LUNG DISEASE 1 0.0000
556 PAIN IN EXTREMITY 6 0.0000
557 DYSPEPSIA 2 0.0000
558 DRY EYE 1 0.0000
559 ARTHRALGIA 8 0.0000
560 ABDOMINAL DISTENSION 2 0.0000
561 MUSCULOSKELETAL PAIN 1 0.0000
562 SPEECH DISORDER 1 0.0000
563 DIARRHOEA 12 0.0000
564 DISTURBANCE IN ATTENTION 1 0.0000
565 ANAPHYLACTIC REACTION 1 0.0000
566 MEDICATION ERROR 1 0.0000
567 NECK PAIN 1 0.0000
568 BLISTER 1 0.0000
569 OXYGEN SATURATION DECREASED 1 0.0000
570 URINARY TRACT INFECTION 3 0.0000
571 LETHARGY 1 0.0000
572 ABDOMINAL PAIN 4 0.0000
573 IRRITABILITY 1 0.0000
574 FEELING HOT 1 0.0000
575 VISUAL IMPAIRMENT 2 0.0000
576 ASTHENIA 6 0.0000
577 HYPERHIDROSIS 2 0.0000
578 AMNESIA 1 0.0000
579 PRODUCT DOSE OMISSION 1 0.0000
580 NAUSEA 12 0.0000
581 BLOOD PRESSURE DECREASED 1 0.0000
582 NEOPLASM MALIGNANT 1 0.0000
583 INJECTION SITE REACTION 1 0.0000
584 BURNING SENSATION 1 0.0000
585 THERAPY INTERRUPTED 1 0.0000
586 MOBILITY DECREASED 1 0.0000
587 UNDERDOSE 1 0.0000
588 BRONCHITIS 1 0.0000
589 EPISTAXIS 1 0.0000
590 HYPOAESTHESIA 2 0.0000
591 UNEVALUABLE EVENT 1 0.0000
592 CHRONIC KIDNEY DISEASE 1 0.0000
593 INJECTION SITE SWELLING 1 0.0000
594 HOSPITALISATION 2 0.0000
595 PERIPHERAL SWELLING 2 0.0000
596 DECREASED APPETITE 3 0.0000
597 SKIN EXFOLIATION 1 0.0000
598 MALAISE 5 0.0000
599 PAIN 7 0.0000
600 INSOMNIA 3 0.0000
601 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
602 MUSCLE SPASMS 2 0.0000
603 ANXIETY 3 0.0000
604 DYSPHAGIA 1 0.0000
605 MIGRAINE 1 0.0000
606 PRURITUS 4 0.0000
607 CONTUSION 1 0.0000
608 DRUG INTOLERANCE 1 0.0000
609 PRODUCT DOSE OMISSION ISSUE 3 0.0000
610 HEART RATE INCREASED 1 0.0000
611 SYNCOPE 1 0.0000
612 CHEST DISCOMFORT 1 0.0000
613 ILLNESS 1 0.0000
614 HEADACHE 6 0.0000
615 HAEMORRHAGE 1 0.0000
616 CONSTIPATION 2 0.0000
617 INFLUENZA 1 0.0000
618 PALPITATIONS 1 0.0000
619 CHILLS 1 0.0000
620 FEELING ABNORMAL 2 0.0000
621 JOINT SWELLING 1 0.0000
622 DIZZINESS 4 0.0000
623 LOSS OF CONSCIOUSNESS 1 0.0000
624 PSORIASIS 1 0.0000
625 MEMORY IMPAIRMENT 1 0.0000
626 WEIGHT DECREASED 2 0.0000
627 COUGH 2 0.0000
628 BLOOD PRESSURE INCREASED 1 0.0000
629 DRUG DEPENDENCE 1 0.0000
630 URTICARIA 1 0.0000
631 CEREBROVASCULAR ACCIDENT 1 0.0000
632 MYOCARDIAL INFARCTION 1 0.0000
633 NASOPHARYNGITIS 1 0.0000
634 BLOOD GLUCOSE INCREASED 1 0.0000
635 GAIT DISTURBANCE 1 0.0000
636 ALOPECIA 1 0.0000
637 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
638 ABDOMINAL PAIN UPPER 1 0.0000
639 OVERDOSE 1 0.0000
640 DEPRESSION 1 0.0000
641 FALL 1 0.0000